微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -0.34% | -140% | -154.84% | 108/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.62% | 6.9% | -11.43% | 89/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.7% | 400% | 118.09% | 83/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -3.87% | -121.74% | -555.29% | 109/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.85% | -94.65% | 46.55% | 102/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.58% | -95.25% | 314.29% | 102/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.14% | -97.99% | -99.21% | 106/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 17.8% | -17.05% | 11.95% | 33/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 15.9% | -11.07% | 30.11% | 28/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 12.22% | -5.93% | 75.83% | 27/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 6.95% | -36.47% | -67.61% | 19/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 21.46% | -76.47% | 20.02% | 35/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.88% | -76.79% | 37.64% | 30/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 12.99% | -75.91% | 18.74% | 32/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 10.94% | -32.68% | -88% | 13/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 91.2% | 1048.62% | 18.4% | 11/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 77.03% | 2% | 42.86% | 5/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 53.92% | 1011.75% | 231.82% | 8/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 16.25% | 2% | 104.66% | 2/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 7.94% | -20.76% | 63.71% | 88/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 4.85% | 8.74% | -51.6% | 47/129 | 6.73% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 10.02% | 13.61% | 124.66% | 72/129 | 12.98% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-06-30 | 4.46% | 25.99% | -49.43% | 32/129 | 3.21% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 8.82% | 2.32% | 149.15% | 69/129 | 13.82% | 安旭生物 | 48.71% | 行业排名> |
| 2017-06-30 | 3.54% | 18.39% | -58.93% | 40/129 | 5.9% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-12-31 | 8.62% | -32.39% | 188.29% | 55/129 | 16.21% | 明德生物 | 14.54% | 行业排名> |
| 2016-06-30 | 2.99% | 2% | -76.55% | 38/129 | 6.26% | 迈瑞医疗 | 11% | 行业排名> |
| 2015-12-31 | 12.75% | -52.37% | -52.37% | 34/129 | 15.95% | 安旭生物 | 59.22% | 行业排名> |